Gut microbiota and type 2 diabetes associations: A meta-analysis of 16s studies and their methodological challenges

Jessica Machado,Ana Paula Schaan,Izabela Mamede,Gabriel R Fernandes
DOI: https://doi.org/10.1101/2024.10.01.615711
2024-10-02
Abstract:Diabetes mellitus is a prevalent chronic non-communicable disease, and recent studies have explored the link between gut microbiota and its development. Despite some evidence suggesting an association, the influence of gut microbiota on type 2 diabetes (DM2) remains unclear. A systematic search of PubMed (Janeiro 2016 to 10 December 2023) using the keywords: (16S and diabetes or DM2) and (gut microbiota and diabetes or DM2). The studies included compared gut microbiome diversity between diabetic and non-diabetic adults using 16S rRNA sequencing, excluding children, interventions, and type 1 diabetes. Alpha diversity indices and bacterial mean abundance were analyzed, with statistical assessments using a random-effects model and I2 for heterogeneity. Thirteen studies met the criteria, with the Shannon index being the most commonly used measure. Results showed significant heterogeneity (I2 > 75%) and no notable differences between diabetic and non-diabetic groups. Other indices, such as Chao1 and phylogenetic whole tree, similarly showed no consistent differences. Taxonomic analysis also failed to find phyla consistently correlated with DM2, with variability across studies. The relationship between gut microbiota and diabetes remains uncertain due to technical and biological factors that are often overlooked. The inconsistencies across studies highlight the low reproducibility common in microbiota research.
Bioinformatics
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the association between gut microbiota and type 2 diabetes (DM2), and the evaluation of the reproducibility of this association across different studies. Specifically, this paper systematically reviewed studies using 16S rRNA sequencing technology since 2016 through meta-analysis, comparing the gut microbial diversity of diabetic patients with non-diabetic patients. The study found no significant differences between the diabetes group and the non-diabetes group across multiple indices (such as the Shannon index, Chao1 index, and phylogenetic diversity whole tree index). Additionally, the analysis of specific bacterial abundances did not show consistent trends. These results suggest that due to methodological differences and technical limitations, a clear association between gut microbiota and type 2 diabetes cannot be determined at present. Therefore, the paper emphasizes the importance of standardized methods and suggests that future research should consider more biological variables and confounding factors to improve the reliability and reproducibility of the results.